214 related articles for article (PubMed ID: 20730876)
1. Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy.
Morine KJ; Bish LT; Selsby JT; Gazzara JA; Pendrak K; Sleeper MM; Barton ER; Lee SJ; Sweeney HL
Muscle Nerve; 2010 Nov; 42(5):722-30. PubMed ID: 20730876
[TBL] [Abstract][Full Text] [Related]
2. Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.
Pistilli EE; Bogdanovich S; Goncalves MD; Ahima RS; Lachey J; Seehra J; Khurana T
Am J Pathol; 2011 Mar; 178(3):1287-97. PubMed ID: 21356379
[TBL] [Abstract][Full Text] [Related]
3. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
4. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
5. Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.
Morine KJ; Bish LT; Pendrak K; Sleeper MM; Barton ER; Sweeney HL
PLoS One; 2010 Feb; 5(2):e9176. PubMed ID: 20161803
[TBL] [Abstract][Full Text] [Related]
6. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
7. Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress.
Hulmi JJ; Hentilä J; DeRuisseau KC; Oliveira BM; Papaioannou KG; Autio R; Kujala UM; Ritvos O; Kainulainen H; Korkmaz A; Atalay M
Free Radic Biol Med; 2016 Oct; 99():308-322. PubMed ID: 27554968
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice.
Hoogaars WM; Mouisel E; Pasternack A; Hulmi JJ; Relizani K; Schuelke M; Schirwis E; Garcia L; Ritvos O; Ferry A; 't Hoen PA; Amthor H
Hum Gene Ther; 2012 Dec; 23(12):1269-79. PubMed ID: 22894762
[TBL] [Abstract][Full Text] [Related]
9. Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy.
Liu M; Hammers DW; Barton ER; Sweeney HL
PLoS One; 2016; 11(11):e0166803. PubMed ID: 27870893
[TBL] [Abstract][Full Text] [Related]
10. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo K; Hulmi JJ; Kiviranta R
BMC Musculoskelet Disord; 2017 Jan; 18(1):20. PubMed ID: 28103859
[TBL] [Abstract][Full Text] [Related]
11. Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice.
Fakhfakh R; Lee SJ; Tremblay JP
Cell Transplant; 2012; 21(7):1419-30. PubMed ID: 22449443
[TBL] [Abstract][Full Text] [Related]
12. Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice.
Morris CA; Selsby JT; Morris LD; Pendrak K; Sweeney HL
J Appl Physiol (1985); 2010 Nov; 109(5):1492-9. PubMed ID: 20847128
[TBL] [Abstract][Full Text] [Related]
13. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
[TBL] [Abstract][Full Text] [Related]
14. Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice.
Hulmi JJ; Oliveira BM; Silvennoinen M; Hoogaars WM; Pasternack A; Kainulainen H; Ritvos O
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E171-82. PubMed ID: 23695214
[TBL] [Abstract][Full Text] [Related]
15. Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy.
Amthor H; Hoogaars WM
Curr Gene Ther; 2012 Jun; 12(3):245-59. PubMed ID: 22554312
[TBL] [Abstract][Full Text] [Related]
16. ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo.
Béchir N; Pecchi E; Vilmen C; Le Fur Y; Amthor H; Bernard M; Bendahan D; Giannesini B
FASEB J; 2016 Oct; 30(10):3551-3562. PubMed ID: 27416839
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
[TBL] [Abstract][Full Text] [Related]
18. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice.
Lynch GS; Cuffe SA; Plant DR; Gregorevic P
Neuromuscul Disord; 2001 Apr; 11(3):260-8. PubMed ID: 11297941
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
[TBL] [Abstract][Full Text] [Related]
20. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
